UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 69.013
NA - Nord America 2.250
AS - Asia 273
AF - Africa 9
SA - Sud America 6
OC - Oceania 3
Totale 71.554
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 68.404
US - Stati Uniti d'America 2.234
SE - Svezia 225
CN - Cina 146
UA - Ucraina 137
DE - Germania 94
GB - Regno Unito 52
FI - Finlandia 39
VN - Vietnam 28
TR - Turchia 27
SG - Singapore 21
BE - Belgio 17
FR - Francia 16
IR - Iran 16
CA - Canada 15
IN - India 11
RU - Federazione Russa 8
ZA - Sudafrica 7
TW - Taiwan 5
CH - Svizzera 4
IL - Israele 4
MT - Malta 4
MY - Malesia 4
NL - Olanda 4
AU - Australia 3
IE - Irlanda 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BR - Brasile 2
CO - Colombia 2
PE - Perù 2
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
JP - Giappone 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 71.554
Salva come PNG Salva come JPEG
Città #
Cagliari 68.220
Fairfield 311
Woodbridge 209
Chandler 193
Ashburn 176
Nyköping 175
Houston 154
Ann Arbor 143
Wilmington 113
Seattle 112
Cambridge 102
Dearborn 79
Jacksonville 61
Boardman 44
Beijing 29
Dong Ket 28
Nanjing 28
Redwood City 22
Helsinki 20
Kocaeli 19
San Mateo 19
New York 18
Boston 17
Brussels 17
Shanghai 16
Milan 15
San Diego 15
Toronto 13
Falls Church 12
Los Angeles 12
Mountain View 11
Jiaxing 10
Nanchang 10
Rome 10
London 9
Shenyang 8
Bogazici 7
Changsha 7
Leawood 7
Auburn Hills 6
Augusta 6
Hefei 6
Milwaukee 6
Norwalk 6
Orange 6
Pune 6
Ardabil 5
Atlanta 5
Bari 5
Florence 5
Millbury 5
Phoenix 5
Ploaghe 5
Columbus 4
Guangzhou 4
Hebei 4
Luras 4
Melita 4
Monmouth Junction 4
Monserrato 4
Pretoria 4
Quartu Sant'elena 4
Sassari 4
Verona 4
Zhengzhou 4
Bologna 3
Dublin 3
Durban 3
Jinan 3
Ningbo 3
Selargius 3
Washington 3
Zurich 3
Azzano Decimo 2
Bergamo 2
Bogotá 2
Chicago 2
Clauzetto 2
Kilburn 2
Kunming 2
Lerici 2
Lima 2
Nuoro 2
Palermo 2
Paris 2
Quarrata 2
Saint-Fons 2
Salvador 2
Southwark 2
Suri 2
Taipei 2
Tehran 2
Tianjin 2
Trento 2
Wuhan 2
Acton 1
Alghero 1
Amsterdam 1
Andover 1
Asolo 1
Totale 70.669
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 3.895
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.552
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.413
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.358
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 3.357
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.342
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 3.330
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 3.316
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.258
Global gene expression profile of normal and regenerating liver in young and old mice 3.189
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 2.887
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 2.806
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 2.797
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.753
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 2.725
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.539
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 2.239
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.197
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.105
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.011
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 1.697
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.546
Early metabolic changes in a liver carcinogenesis model 1.025
Early Metabolic Changes in preneoplastc nodules of the liver 857
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 737
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 731
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 646
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 636
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 621
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 600
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 535
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 378
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 302
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 236
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 232
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 223
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 207
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 204
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 184
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 180
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 179
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 176
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 169
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 147
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 104
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 50
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 37
Totale 71.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019542 0 0 0 0 0 0 0 0 0 0 336 206
2019/202014.442 590 507 51 129 5.221 3.742 1.983 450 262 355 386 766
2020/202118.781 532 816 733 5.573 3.262 2.004 1.248 1.166 596 1.123 1.138 590
2021/20225.241 755 347 229 341 512 363 208 190 536 571 598 591
2022/20237.832 448 870 1.016 693 625 876 502 456 520 643 777 406
2023/20246.060 471 248 273 381 723 1.152 1.307 683 349 443 30 0
Totale 71.708